Select from our A to Z index of CMI (Consumer Medicines Information) leaflets for both prescription and over-the-counter medicines. Available as HTML, PDF and large font PDF.
Erythromycin 2% w/w
Consumer Medicine Information
This leaflet answers some common questions about ERYACNE Topical Gel. Please read this leaflet carefully before you start using the gel. It does not contain all the information available on this medicine. It does not take the place of talking to your doctor or pharmacist.
All medicines have risks and benefits. Your doctor has weighed the risks of your using ERYACNE against the benefits expected it will have for you. If you have concerns about using this medicine ask your doctor or pharmacist.
Keep this leaflet with your tube. You may wish to read it again later.
Before you use ERYACNE Topical Gel tell your doctor if:
ERYACNE is used for mild to moderate acne and works by inactivating the bacteria which are known to cause acne.
Apply a thin film of ERYACNE twice daily to the affected areas. It should be applied to a dry, clean face to lessen the possibility of irritation.
As a rule an 8 week treatment will be necessary, but if the condition persists, the period of treatment may be longer.
ERYACNE should not come into contact with the eyes, lips or the lining of the mouth or nose. Do not apply to broken skin. If accidental contact occurs, rinse thoroughly with water.
Be careful not to use cosmetic products containing alcohol, abrasives or medicated soaps. These may cause an extra irritant or drying effect.
ERYACNE is not to be swallowed.
Allow the gel to dry on the skin before applying other products or smoking.
If a serious reaction occurs, discontinue use of ERYACNE and consult your doctor.
Insert diagrams with instructions here.
All medicines may cause unwanted effects, but the information above is to help you use ERYACNE in the safest way. Medicines can react with each other, so please tell your doctor about every medicine you are using, so that the doctor can check whether any unwanted effects may occur. At this time, not all unwanted effects may be known. You may check with your doctor or pharmacist for more information if you have a problem.
It is important that you tell your doctor about anything unusual that you experience, even if it is not mentioned in this leaflet. The unwanted side effects with ERYACNE include dryness, tenderness, itching, redness, oiliness and burning sensation.
ERYACNE Topical Gel contains erythromycin 2% (20mg/g) in a clear gel base for application to the skin. An ERYACNE 4% (40 mg/g) erythromycin gel is also available in New Zealand only.
In addition ERYACNE contains the following inactives:butylhydroxytoluene, hydroxypropylcellulose and ethyl alcohol.
Australian Registration Number : Aust R 43979
ERYACNE is intended for external use only. If swallowed, contact your doctor or poisons centre.
Eryacne is a thin alcohol based gel and is therefore flammable. Keep away from sources of heat and store in a cool place below 25 degrees and out of reach of children.
Your doctor may suggest the use of other medication along with ERYACNE.
Should you have any questions regarding this product, please contact your doctor or pharmacist.
Galderma Australia Pty Ltd
9 Rodborough Road,
Frenchs Forest NSW 2086.
Distributed in New Zealand by:
76 Leonard Road, Mt Wellington
Auckland, New Zealand.
Date of issue of patient information - June 1996.
This leaflet provides a summary of some of the important things you need to know about ERYACNE Topical Gel. Only your doctor and pharmacist are able to weigh up all the relevant facts and you should consult them about all aspects of this medicine as it relates to you.
Published by MIMS/myDr May 2011